GSE107577
Fine-tuning Mybl2 levels are required for proper MET process during somatic reprogramming [ATAC-Seq]
Genome wide data investigating the role of Mybl2 in reprogramming Overall design: 3 biological replicates of ATAC-seq in control and Mybl2  overexpression conditions at day 3 of reprogramming in doxycycline inducible MEFs. Two biological replicates for controls at day 0 (two technical replicates of each). Two biological replicates of Mybl2  overexpression at day 3 with no induction of reprogramming.